Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000200406-13-000107
Filing Date
2013-10-18
Accepted
2013-10-18 13:43:48
Documents
2
Period of Report
2013-10-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1535
2 MARK B. MCCLELLAN POWER OF ATTORNEY mcclellanpoa.htm EX-24 3200
  Complete submission text file 0000200406-13-000107.txt   6102
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Issuer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1212
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE BROOKINGS INSITUTION 1775 MASSACHUSETTS AVE., NW WASHINGTON DC 20036
Business Address
McClellan Mark B. (Reporting) CIK: 0001567006 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-03215 | Film No.: 131159042